Publicacións en colaboración con investigadores/as de Aix-Marseille University (18)

2022

  1. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up

    European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103

  2. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis

    Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412

  3. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis

    European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058

  4. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  5. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Consensus on diagnosis and management of Cushing's disease: a guideline update

    The lancet. Diabetes & endocrinology, Vol. 9, Núm. 12, pp. 847-875

  2. European guideline on igg4-related digestive disease — ueg and sgf evidence-based recommendations

    Russian Journal of Gastroenterology, Hepatology, Coloproctology, Vol. 31, Núm. 1, pp. 80-114

  3. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

    The Lancet Respiratory Medicine, Vol. 9, Núm. 3, pp. 260-274

  4. Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

    Journal of the Endocrine Society, Vol. 5, Núm. 3

2020

  1. Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” (Pancreatology (2018) 18(8) (847–854), (S1424390318306938), (10.1016/j.pan.2018.09.016))

    Pancreatology

2017

  1. A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway

    Surgical Infections, Vol. 18, Núm. 8, pp. 846-853

  2. Erratum: Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA). [World J Emerg Surg. 11, (2016) (33)] DOI: 10.1186/s13017-016-0089-y

    World Journal of Emergency Surgery

  3. Risk score for cardiac surgery in active left-sided infective endocarditis

    Heart, Vol. 103, Núm. 18, pp. 1435-1442

2016

  1. Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA)

    World Journal of Emergency Surgery, Vol. 11, Núm. 1

2007

  1. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas

    Endocrinologia y Nutricion, Vol. 54, Núm. 8

2006

  1. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas

    Clinical Endocrinology, Vol. 65, Núm. 2, pp. 265-273

2005

  1. Consensus statement: Medical management of acromegaly

    European Journal of Endocrinology, Vol. 153, Núm. 6, pp. 737-740

2003

  1. Diagnosis and treatment of acromegaly complications

    Journal of Endocrinological Investigation, Vol. 26, Núm. 12, pp. 1242-1247